Any feedback?
Please rate this page
(search_result.php)
(0/150)

BRENDA support

Refine search

Search Disease/ Diagnostics

show results
Refine your search

Search term:

Results 1 - 10 of 718 > >>
EC Number Disease PubMed ID Title of Publication Category Confidence Level
Display the word mapDisplay the reaction diagram Show all sequences 2.7.12.1Adenocarcinoma 19818968 Expression of dual-specificity tyrosine-(Y)-phosphorylation-regulated kinase 2 (DYRK2) can be a favorable prognostic marker in pulmonary adenocarcinoma. causal interaction
diagnostic usage
ongoing research
therapeutic application
1
4
4
1
Display the word mapDisplay the reaction diagram Show all sequences 2.7.12.1Adenocarcinoma 25712377 DYRK2 regulates epithelial-mesenchymal-transition and chemosensitivity through Snail degradation in ovarian serous adenocarcinoma. causal interaction
diagnostic usage
ongoing research
therapeutic application
3
3
2
4
Display the word mapDisplay the reaction diagram Show all sequences 2.7.12.1Adenocarcinoma 26341817 Silencing of DYRK2 increases cell proliferation but reverses CAM-DR in Non-Hodgkin's Lymphoma. causal interaction
diagnostic usage
unassigned
4
2
0
Display the word mapDisplay the reaction diagram Show all sequences 2.7.12.1Adenocarcinoma 27532268 Low Expression of DYRK2 (Dual Specificity Tyrosine Phosphorylation Regulated Kinase 2) Correlates with Poor Prognosis in Colorectal Cancer. causal interaction
diagnostic usage
ongoing research
therapeutic application
4
4
4
1
Display the word mapDisplay the reaction diagram Show all sequences 2.7.12.1Adenocarcinoma 28502078 Dual-specificity tyrosine-regulated kinase 2 is a suppressor and potential prognostic marker for liver metastasis of colorectal cancer. causal interaction
diagnostic usage
ongoing research
unassigned
4
4
4
0
Display the word mapDisplay the reaction diagram Show all sequences 2.7.12.1Adenocarcinoma 30343272 DYRK1A modulates c-MET in pancreatic ductal adenocarcinoma to drive tumour growth. causal interaction
ongoing research
therapeutic application
unassigned
4
4
4
0
Display the word mapDisplay the reaction diagram Show all sequences 2.7.12.1Adenocarcinoma 31838052 Licocoumarone induces BxPC-3 pancreatic adenocarcinoma cell death by inhibiting DYRK1A. causal interaction
therapeutic application
unassigned
4
3
0
Display the word mapDisplay the reaction diagram Show all sequences 2.7.12.1Adenocarcinoma 32687947 The USP22 promotes the growth of cancer cells through the DYRK1A in pancreatic ductal adenocarcinoma. causal interaction
diagnostic usage
ongoing research
therapeutic application
3
3
2
1
Display the word mapDisplay the reaction diagram Show all sequences 2.7.12.1Adenocarcinoma of Lung 12874018 Amplification and overexpression of the dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2 (DYRK2) gene in esophageal and lung adenocarcinomas. causal interaction
diagnostic usage
unassigned
4
2
0
Display the word mapDisplay the reaction diagram Show all sequences 2.7.12.1Adenocarcinoma of Lung 33368138 Frequent DYRK2 gene amplification in micropapillary element of lung adenocarcinoma - an implication in progression in EGFR-mutated lung adenocarcinoma. diagnostic usage
ongoing research
therapeutic application
unassigned
2
2
1
0
Results 1 - 10 of 718 > >>